JP2009522239A - トリテルペンキノンおよびトリテルペンフェノール誘導体、ならびに腫瘍および寄生生物性疾患の治療のためのそれらの適用 - Google Patents

トリテルペンキノンおよびトリテルペンフェノール誘導体、ならびに腫瘍および寄生生物性疾患の治療のためのそれらの適用 Download PDF

Info

Publication number
JP2009522239A
JP2009522239A JP2008547980A JP2008547980A JP2009522239A JP 2009522239 A JP2009522239 A JP 2009522239A JP 2008547980 A JP2008547980 A JP 2008547980A JP 2008547980 A JP2008547980 A JP 2008547980A JP 2009522239 A JP2009522239 A JP 2009522239A
Authority
JP
Japan
Prior art keywords
alkyl
group
unsubstituted
substituted
independently hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008547980A
Other languages
English (en)
Japanese (ja)
Inventor
フアン、カルロス、ラカル、サンフアン
アナ、ラミレス、デ、モリナ
モニカ、バニェス、コロネル
アンヘル、グティエレス、ラベロ
アナ、エステベス、ブラウン
ドゥルセ、ヤスミン、メサ、シベリオ
エリサ、ペレス、サカウ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Universidad de La Laguna
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Universidad de La Laguna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Universidad de La Laguna filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of JP2009522239A publication Critical patent/JP2009522239A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
JP2008547980A 2005-12-30 2006-12-29 トリテルペンキノンおよびトリテルペンフェノール誘導体、ならびに腫瘍および寄生生物性疾患の治療のためのそれらの適用 Pending JP2009522239A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503263A ES2277568B1 (es) 2005-12-30 2005-12-30 Derivados de triterpenoquinona y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
PCT/EP2006/070276 WO2007077203A2 (fr) 2005-12-30 2006-12-29 Derives de triterpenequinone et de triterpenephenol et leur application pour le traitement de tumeurs et de maladies parasitaires

Publications (1)

Publication Number Publication Date
JP2009522239A true JP2009522239A (ja) 2009-06-11

Family

ID=37946257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008547980A Pending JP2009522239A (ja) 2005-12-30 2006-12-29 トリテルペンキノンおよびトリテルペンフェノール誘導体、ならびに腫瘍および寄生生物性疾患の治療のためのそれらの適用

Country Status (11)

Country Link
EP (1) EP1976533A2 (fr)
JP (1) JP2009522239A (fr)
KR (1) KR20080083044A (fr)
CN (1) CN101351211A (fr)
AU (1) AU2006334359A1 (fr)
BR (1) BRPI0620845A2 (fr)
CA (1) CA2635318A1 (fr)
ES (1) ES2277568B1 (fr)
MX (1) MX2008008556A (fr)
RU (1) RU2008131311A (fr)
WO (1) WO2007077203A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101405403B (zh) 2005-04-13 2013-07-10 科学研究高等机关 鉴定用于癌症治疗的化合物的体外方法
WO2009026163A1 (fr) * 2007-08-17 2009-02-26 Burnham Institute For Medical Research Compositions et procédés pour inhiber la croissance et la métastase d'un mélanome
CN101434635B (zh) * 2007-11-16 2012-05-16 上海华拓医药科技发展股份有限公司 一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法
US20100068302A1 (en) * 2008-09-17 2010-03-18 Traslational Cancer Drugs Pharma, S.L. Methods and compositions for the treatment of cancer
WO2010049173A1 (fr) * 2008-10-31 2010-05-06 Cenix Bioscience Gmbh Utilisation d’inhibiteurs de kinases hôtes pour traiter les maladies infectieuses
CA2808359C (fr) * 2010-08-23 2019-09-24 Suzhou Neupharma Co., Ltd. Analogues de celasterol et compositions pharmaceutiques en renfermant
BR112018008103A2 (pt) 2015-10-23 2018-11-06 Erx Pharmaceuticals, Inc. análogos de celastrol
EP3480207A4 (fr) * 2016-07-04 2020-03-11 Xiamen University Ligand de récepteur nucléaire orphelin nur77 et son application
ES2899114T3 (es) 2016-07-25 2022-03-10 Nerviano Medical Sciences Srl Análogos de purina y 3-deazapurina como inhibidores de colina cinasa
US11117901B2 (en) 2017-07-11 2021-09-14 Nerviano Medical Sciences S.R.L. Substituted pyrazolo[4,3-h]quinazolines as choline kinase inhibitors
WO2020257658A1 (fr) 2019-06-20 2020-12-24 University Of Iowa Research Foundation Nanoparticules comprenant des quinone-méthides et compositions à utiliser
CN113827599A (zh) * 2021-09-23 2021-12-24 天津国际生物医药联合研究院 去甲泽拉木醛在抗登革病毒感染中的潜在应用
CN116023426A (zh) * 2022-12-30 2023-04-28 上海海洋大学 去甲泽拉木醛衍生物及其在制备抗癌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328309A (en) * 1980-07-02 1982-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method for producing tripdiolide, triptolide and celastrol
DE4117854A1 (de) * 1991-05-31 1992-12-03 Wiemann Wolfram Verwendung mindestens eines celastroloids als bestandteil fuer ein arzneimittel zur behandlung von erkrankungen des rheumatoiden formenkreises, insbesondere rheumatismus
US5650167A (en) * 1995-11-16 1997-07-22 Dawa Incorporated Method and composition for treating hepatitis B
ES2117950B1 (es) 1996-08-02 1999-09-16 Univ Granada Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.
CN1155610C (zh) * 2002-11-05 2004-06-30 浙江大学 具有抗氧化和抗肿瘤活性扁蒴藤素系列衍生物及合成方法
US20040220267A1 (en) * 2003-02-07 2004-11-04 Devlin J. P. Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases

Also Published As

Publication number Publication date
ES2277568B1 (es) 2008-04-01
RU2008131311A (ru) 2010-02-10
CN101351211A (zh) 2009-01-21
WO2007077203A3 (fr) 2007-08-30
KR20080083044A (ko) 2008-09-12
BRPI0620845A2 (pt) 2011-11-22
CA2635318A1 (fr) 2007-07-12
AU2006334359A1 (en) 2007-07-12
MX2008008556A (es) 2008-09-26
WO2007077203A2 (fr) 2007-07-12
EP1976533A2 (fr) 2008-10-08
AU2006334359A2 (en) 2008-08-07
ES2277568A1 (es) 2007-07-01

Similar Documents

Publication Publication Date Title
JP2009522239A (ja) トリテルペンキノンおよびトリテルペンフェノール誘導体、ならびに腫瘍および寄生生物性疾患の治療のためのそれらの適用
Tan et al. Synthesis, DNA binding and cytotoxicity of new pyrazole emodin derivatives
US20060234956A1 (en) Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof
Chien et al. Secondary metabolites from the root of Ehretia longiflora and their biological activities
Li et al. Synthesis, antitumor activity evaluation and mechanistic study of novel hederacolchiside A1 derivatives bearing an aryl triazole moiety
JP4425109B2 (ja) 腫瘍/癌細胞の増殖の抑制活性を有するガンボージ樹脂から単離した化合物及びその化合物を含む薬学的組成物
JP2017048195A (ja) ガンおよび他の疾患を治療するための新規化合物
Ma et al. Synthesis and anti-cancer activity studies of dammarane-type triterpenoid derivatives
JP3285361B2 (ja) コルヒチン骨格化合物、それらの医薬としての用途、及びそれらを含有する組成物
Ulusoy et al. Design, semi-synthesis and examination of new gypsogenin derivatives against leukemia via Abl tyrosine kinase inhibition and apoptosis induction
WO2023125928A1 (fr) Inhibiteur de ménine et son utilisation
Zhu et al. Design and synthesis of NAD (P) H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties
Kang et al. Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia
Munikishore et al. Structurally modified Cyclovirobuxine-D Buxus alkaloids as effective analgesic agents through Cav3. 2 T-Type calcium channel inhibition
Liu et al. Dihydromyricetin from Ampelopsis grossedentata and its derivatives: Structural characterization and anti-hepatocellular carcinoma activity
Zhang et al. A pair of new tirucallane triterpenoid epimers from the stems of Picrasma quassioides
CN109651377B (zh) 一种治疗癌症的化合物及其用途
JP2009274956A (ja) ニーム種子由来の悪性腫瘍治療薬
CN110698443A (zh) 一种shp2小分子选择性抑制剂及其在制备抗肺癌药物中的应用
CZ282473B6 (cs) Bis(fenyl)ethanové deriváty, způsob jejich přípravy a farmaceutická kompozice tyto deriváty obsahující
Zhang et al. Prunolactones AG, proangiogenic isocoumarin derivatives with an unusual 6/6/6/6/6 spiropentacyclic skeleton from the endophytic fungus Phomopsis prunorum
US9175030B2 (en) Derivatives of avicin D and methods of making and using thereof
Sun et al. Polycyclic polyprenylated acylphloroglucinol derivatives from Hypericum pseudohenryi
TWI227238B (en) Novel pyranocoumarin compounds and their applications
Wang et al. (±)-Yanhusuomide A, a pair of ornithine-fused benzylisoquinoline enantiomers from Corydalis yanhusuo